Skip to main content

Ming Chen

Associate Professor of Pathology
Pathology
Duke Box 103863, Durham, NC 27710
905 S LaSalle St, GSRB1, Rm 2014, Durham, NC 27710

Overview


Our laboratory is interested in understanding the molecular and genetic events underlying cancer progression and metastasis. The focus of our work is a series of genetically engineered mouse models that faithfully recapitulate human disease. Using a combination of mouse genetics, omics technologies, cross-species analyses and in vitro approaches, we aim to identify cancer cell–intrinsic and –extrinsic mechanisms driving metastatic cancer progression, with a long–term goal of developing new therapeutic strategies for preventing and treating metastatic disease. 

Current Appointments & Affiliations


Associate Professor of Pathology · 2025 - Present Pathology, Clinical Science Departments
Associate Research Professor of Cell Biology · 2022 - Present Cell Biology, Basic Science Departments
Member of the Duke Cancer Institute · 2018 - Present Duke Cancer Institute, Institutes and Centers

In the News


Published December 3, 2024
Research & Innovation Seed Grants Total Nearly $2 Million
Published May 17, 2023
Duke Scientists Uncover Ferroptosis as a Potential “Achilles Heel” in RB1-Deficient Prostate Cancer
Published April 26, 2018
Prostate Cancer Metastasis — Fueled by Fat?

View All News

Recent Publications


Special collection on novel targeted therapies for advanced prostate cancer.

Journal Article J Pharmacol Exp Ther · December 17, 2025 Featured Publication Full text Link to item Cite

Targeting SREBP-dependent lipogenesis potentiates the anti-tumor activity of docetaxel by increasing membrane permeability and intracellular drug accumulation.

Journal Article Oncogene · November 2025 Featured Publication Lipid metabolism is among the most frequently dysregulated metabolic processes in human cancer, yet how cellular lipids, the end products of lipogenesis, and their composition are altered to support various aspects of cancer remains poorly understood. Here ... Full text Open Access Link to item Cite
View All Publications

Recent Grants


Developing A Novel Combinatorial Therapy for Lethal Neuroendocrine Prostate Cancer

ResearchPrincipal Investigator · Awarded by National Cancer Institute · 2022 - 2027

Targeting Ferroptosis in Lethal RB1 Deficient Prostate Cancer

ResearchPrincipal Investigator · Awarded by National Cancer Institute · 2022 - 2027

Engineering Large Chromosomal Deletions in Mice to Advance Precision Oncology for Prostate Cancer

ResearchPrincipal Investigator · Awarded by National Cancer Institute · 2022 - 2027

View All Grants

Education, Training & Certifications


University of Rochester · 2009 Ph.D.